Categories: AddictionNews

Massachusetts University First to Pilot NALCAM, a New Technology Advancing Naloxone Carriage and Overdose Prevention

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

BOSTON, May 13, 2025 /PRNewswire/ — Q2i, a leader in digital health innovation, has launched NALCAM, a pioneering technology designed to increase the carriage of Naloxone—a life-saving medication used to reverse opioid overdoses. This initiative aims to improve access and consistent carrying of Naloxone, helping individuals respond more effectively in critical overdose situations.

Developed by Q2i’s contingency management division, NALCAM uses motivational incentives to encourage individuals to carry Naloxone regularly. The program helps bridge the gap between Naloxone distribution and real-world usage, supporting rapid intervention when it matters most.

Worcester Polytechnic Institute (WPI) was the first institution to participate in the NALCAM pilot, providing an opportunity to explore how higher education settings can support community-focused public health strategies.

Q2i CEO Steve Jenkins stated, “We designed NALCAM to support people in making potentially life-saving choices. By combining behavioral science with public health tools, this technology empowers individuals and organizations to prioritize safety through regular Naloxone carriage.”

Dr. Matilde Castiel, Commissioner of Health and Human Services for Worcester, emphasized the broader significance of the program: “Worcester is home to many colleges and universities, and initiatives like NALCAM show how higher education can proactively address public health challenges. This program encourages immediate responses to overdose emergencies and has the potential to save lives, setting a new standard for public health interventions.”

Key Benefits of NALCAM Include:

Harm Reduction: Empowers bystanders to respond effectively to overdoses.

Stigma Reduction: Supports open, informed conversations around addiction and recovery.

Community Impact: Builds awareness and preparedness at the individual and institutional levels.

As the opioid crisis continues to affect communities nationwide, NALCAM represents a forward-thinking approach to harm reduction. Q2i welcomes collaboration with campuses, health systems, and community partners seeking to enhance overdose prevention efforts.

For more information or partnership inquiries, visit Q2i.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/massachusetts-university-first-to-pilot-nalcam-a-new-technology-advancing-naloxone-carriage-and-overdose-prevention-302453641.html

SOURCE Q2i

Staff

Recent Posts

Strategikon Pharma Secures Growth Loan to Expand Sales and Client Support Teams Amid Rising Demand

Company-friendly debt solution will support expansion of the rapidly-growing innovative software company SAN FRANCISCO, June…

37 minutes ago

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

SAN DIEGO, June 10, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), aligned with its commitments…

7 hours ago

Applied Medical Technology, Inc. Unveils Redesigned Mobile App Aligned with Recent Website Refresh

BRECKSVILLE, Ohio., June 10, 2025 /PRNewswire/ -- Applied Medical Technology, Inc. (AMT), a leader in innovative…

7 hours ago

NCPDP Foundation Awards $200,000 Grant to CARIN Alliance for Consumer-Facing Real-Time Pharmacy Benefit Check Project

SCOTTSDALE, Ariz., June 10, 2025 /PRNewswire/ -- The NCPDP Foundation is pleased to announce the approval…

7 hours ago

CSD Charts a New Course for Career Growth with Launch of Career Rewards

Milestone recognition, mentorship, and advancement opportunities come together as part of the Career Compass initiative…

7 hours ago

The YMCA of Metropolitan Chicago Names Adam M. Alonso as Next President and CEO

Veteran nonprofit executive and youth development champion Adam M. Alonso named President and CEO of…

7 hours ago